friends of FSH Research

Funding Research for
FSH Muscular Dystrophy Dots

IncuCyte brings live cell imaging to Genea Biocells

— October 28, 2016

The first application for this technology is FSHD disease modelling and drug discovery.

Acceleron to Webcast Overview of ACE-083 Phase 2 Trial

— October 27, 2016

Webcast to be held Oct 28, 2016 at 10:00 a.m. EDT with Dr. Statland. Archive available on website.

Grant Awarded to Develop Outcome Measure

— October 26, 2016

A proposal to study the histopathological features of muscle in a large biobank from FSHD patients and their first degree family members.

Grant Awarded to Explore Innate Immunity

— October 25, 2016

Development of an in vitro model of FSHD innate immunity.

aTyr Pharma ongoing Phase 1b/2 Clinical Trials

— October 6, 2016

aTyr Pharma, a company engaged in the discovery and development of therapeutics to address severe rare diseases, is currently conducting two trials of Resolaris (ATYR1940) in patients with rare myopathies with an immune component.